Literature DB >> 22136554

Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.

N Leban1, C Abarrategui-Garrido, E Fariza-Requejo, C Amiñoso-Carbonero, S Pinto, J B Chibani, A H Khelil, P Sánchez-Corral.   

Abstract

Several polymorphisms in the complement components factor H and CFHR1 are associated with higher risk to develop atypical Haemolytic Uraemic Syndrome (aHUS) in Caucasians. We have determined the prevalence of these polymorphisms in Tunisian controls by using genetic and immunological techniques. No differences in the frequency of the factor H risk alleles c.-331C>T, c.2089A>G or c.2881G>T between Tunisian and Caucasians were found. On the contrary, the analysis of CFHR1 polymorphism revealed a higher frequency of Tunisian individuals homozygous for the CFHR1*Del (deleted) allele, and of individuals presenting the CFHR1*A phenotype. These results suggest distinct contributions of factor H and CFHR1 polymorphisms to aHUS in Tunisian and Caucasian populations.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136554     DOI: 10.1111/j.1744-313X.2011.01071.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  6 in total

Review 1.  Anti-complement-factor H-associated glomerulopathies.

Authors:  Marie-Agnes Dragon Durey; Aditi Sinha; Shambhuprasad Kotresh Togarsimalemath; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

Review 2.  The Genetics of Ultra-Rare Renal Disease.

Authors:  Melissa Muff-Luett; Carla M Nester
Journal:  J Pediatr Genet       Date:  2016-02-23

3.  Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.

Authors:  Sungeun Kim; Shanker Swaminathan; Mark Inlow; Shannon L Risacher; Kwangsik Nho; Li Shen; Tatiana M Foroud; Ronald C Petersen; Paul S Aisen; Holly Soares; Jon B Toledo; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Brenna C McDonald; Martin R Farlow; Bernardino Ghetti; Andrew J Saykin
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

4.  Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.

Authors:  Lucy V Holmes; Lisa Strain; Scott J Staniforth; Iain Moore; Kevin Marchbank; David Kavanagh; Judith A Goodship; Heather J Cordell; Timothy H J Goodship
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

5.  High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B.

Authors:  Richard B Pouw; Irene Gómez Delgado; Alberto López Lera; Santiago Rodríguez de Córdoba; Diana Wouters; Taco W Kuijpers; Pilar Sánchez-Corral
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

6.  Factor H Autoantibodies and Complement-Mediated Diseases.

Authors:  Yuzhou Zhang; Nicolo Ghiringhelli Borsa; Dingwu Shao; Arthur Dopler; Michael B Jones; Nicole C Meyer; Gabriella R Pitcher; Amanda O Taylor; Carla M Nester; Christoph Q Schmidt; Richard J H Smith
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.